GILD

Gilead Sciences, Inc. News Headlines

$68.7701
*  
0.6001
 negative 
0.88%
Get GILD Alerts
*Delayed - data as of Apr. 16, 2014 9:45 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dynavax Receives Milestone Payments from AstraZeneca - Analyst Blog
3/5/2014 12:40:01 PM - Zacks.com

Pipeline Setback Overshadows XOMA's Q4 - Analyst Blog
3/5/2014 11:52:01 AM - Zacks.com

Narrower-than-Expected Q4 Loss at GTx - Analyst Blog
3/5/2014 10:50:01 AM - Zacks.com

Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape
3/5/2014 10:25:01 AM - Zacks.com

Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape
3/5/2014 10:18:01 AM - Zacks.com

Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14)
3/5/2014 6:13:00 AM - Seeking Alpha

Bull of the Day: Quintiles (Q) - Bull of the Day
3/5/2014 3:59:00 AM - Investopedia

AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog
3/4/2014 6:10:01 PM - Zacks.com

Isis Pharma Slips on Wider-Than-Expected Q4 Loss - Analyst Blog
3/4/2014 4:06:01 PM - Zacks.com

Theravance to Split in Q2 - Analyst Blog
3/4/2014 1:00:01 PM - Zacks.com

Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog
3/4/2014 12:30:01 PM - Zacks.com

Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
3/4/2014 12:00:01 PM - Zacks.com

Narrower-than-Expected Loss at Dendreon Drives Shares Up - Analyst Blog
3/4/2014 11:40:01 AM - Zacks.com

EU Review for The Medicines Co.'s Oritavancin - Analyst Blog
3/3/2014 6:55:01 PM - Zacks.com

Actelion Gains on QIDP and Fast Track Status - Analyst Blog
3/3/2014 6:10:01 PM - Zacks.com

Update on Anacor's AN2728 - Analyst Blog
3/3/2014 4:50:01 PM - Zacks.com

Biogen Keeps Momentum Going With MS Drug Tecfidera
3/3/2014 3:05:00 PM - Investor's Business Daily

Are These Biotechs Part of Your Portfolio? - Analyst Blog
3/3/2014 11:52:01 AM - Zacks.com

Earnings Decline YoY at Alkermes - Analyst Blog
2/28/2014 1:50:01 PM - Zacks.com

Noteworthy ETF Inflows: IBB, BIIB, GILD, AMGN
2/28/2014 12:43:41 PM - BNK Invest

Cara Therapeutics (CARA) Zooms: Stock Up 12.4% - Tale of the Tape
2/28/2014 10:39:01 AM - Zacks.com

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2014
2/28/2014 10:00:01 AM - NASDAQ.com News

bluebird bio (BLUE) Zooms: Stock Up 7.2% - Tale of the Tape
2/28/2014 9:51:01 AM - Zacks.com

Mylan Beats on Q4 Earnings & Revenues - Analyst Blog
2/27/2014 2:23:01 PM - Zacks.com

FDA Designation for Bristol-Myers Candidate - Analyst Blog
2/25/2014 6:20:01 PM - Zacks.com